Glucose-specific regulation of aldose reductase in human retinal pigment epithelial cells in vitro

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1554-1560

  Henry, Douglas N ^a,d   Frank, Robert N ^b   Hootman, Seth R ^a   Rood, Sandra E ^a   Heilig, Charles W ^c   Busik, Julia V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; COMPLEMENTARY DNA; GALACTOSE; GLUCOSE; LACTIC ACID; MANNITOL; MESSENGER RNA;

ARTICLE; CELL CULTURE; ENZYME REGULATION; EPITHELIUM CELL; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA;

3-O-METHYLGLUCOSE; ALDEHYDE REDUCTASE; BLOTTING, NORTHERN; CELLS, CULTURED; DNA PROBES; FEMALE; GALACTOSE; GLUCOSE; HUMANS; IMMUNOBLOTTING; LACTIC ACID; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; RNA, MESSENGER; SUBSTRATE SPECIFICITY;

EID: 0034102454     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Gabbay KH. The sorbitol pathway and the complications of diabetes. N Engl J Med 1973;288:831-836.
2. Kinoshita JH, Fukushi S, Kador P, Merola LO. Aldose reductase in diabetic complications of the eye. Metabolism. 1979;28:462-469.
3. Busik JV, Hootman SR, Greenidge CA, Henry DN. Glucose-specific regulation of aldose reductase in Capan-1 human pancreatic duct cells in vitro. J Clin Invest. 1997;100:1685-1692.
4. Aida K, Tawata M, Ikegishi Y, Onaya T. Induction of rat aldose reductase gene transcription is mediated through the cis-element, osmotic response element (ORE): increased synthesis and/or activation by phosphorylation of ORE-binding protein is a key step. Endocrinology. 1999;140:609-617.
5. Carper, D, Kaneko M, Stark H, Hohman T. Increase in aldose reductase mRNA in dog lens epithelial cells under hypertonic conditions. Exp Eye Res. 1990;50:743-749.
6. Garcia-Perez A, Burg MB. Role of organic osmolytes in adaptation of renal cells to high osmolality. J Membr Biol. 1991;119:1-13.
7. Smardo FL, Burg MB, Garcia-Perez A. Kidney aldose reductase gene transcription is osmotically regulated. Am J Physiol. 1992; 262:C776-C782.
8. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes. N Engl J Med. 1993;329:977-986.
9. Foulds WS. The choroidal circulation and retinal metabolism: Part 2: an overview. Eye. 1990;4:243-248.
10. Del Monte MA, Maumenee IH. New techniques for in vitro culture of human retinal pigment epithelium. Birth Defects Orig Artic Ser. 1980;16:327-338.
11. Bito LZ, DeRoussear J. Transport function of the blood-retinal barrier system and the micro-environment of the retina. In:. Zinn KM, Mamor MF, eds. The Retinal Pigment Epithelium. Cambridge, MA: Harvard University Press. 1979:133-162.
12. MacGregor LC, Matschinsky FM. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats. J Clin Invest. 1985;76:887-889.
13. Weinberger D, Fink-Cohen S, Gaton DD, Priel E, Yassur Y. Non-retinovascular leakage in diabetic maculopathy. Br J Ophthalmol. 1995;79:728-731.
14. Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol. 1989;134:231-235.
15. Vinores SA. Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothclium and retinal pigment epithelium. Histochem J. 1993;25:648-663.
16. Bek T. Transretinal histopathological changes in capillary-free areas of diabetic retinopathy. Acta Ophthalmol. 1994;72:409-415.
17. Tso MO, Cunha-Vaz JG, Shih CY, Jones CW. Clinicopathologic study of blood-retinal harrier in experimental diabetes mellitus. Arch Ophthalmol. 1980;98:2032-2040.
18. Shiels IA, Zhang S, Ambler J, Taylor SM. Vascular leakage stimulates phenotype alteration in ocular cells, contributing to the pathology of proliferative vitreoretinopathy. Med Hypotheses. 1998;50:113-117.
19. Del Monte MA, Rabbani R, Diaz TC, et al. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose: in vitro model of myo-inositol depletion hypothesis of diabetic complications. Diabetes 1991;40:1335-1345.
20. MacGregor LC, Matschinsky FM. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism. 1986;35(suppl 1):28-34.
21. Khatami M, Rockey JH. Regulation of uptake of inositol by glucose in cultured retinal pigment epithelial cells. Biochem Cell Biol. 1988;66:951-957.
22. Marano CW, Matschinsky FM. Biochemical manifestations of diabetes mellitus in microscopic layers of the cornea and retina. Diabetes Metab Rev. 1989;5:1-15.
23. Dircks C, Williams EH, Campochiaro PA. High glucose concentrations inhibit protein synthesis in retinal pigment epithelium in vitro. Exp Eye Res. 1987;44:951-958.
24. MacGregor LC, Matschinsky FM. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism. 1986;35(suppl 1):28-34.
25. Handa JT, Verzijl N, Matsunaga H, et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci. 1999;40:775-779.
26. Lu M, Kuroki M, Amano S, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998;101:1219-1224 .
27. Esser P, Heimann K, Bartz-Schmidt KU, et al. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. Exp Eye Res. 1997;65:365-378.
28. Frank RN, Amin R, Kennedy A, Hohman TC. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol. 1997;115:1036-1047.
29. Vinores SA, Campochiaro PA. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition. Exp Eye Res. 1989;49:495-510.
30. Henry DN, Del Monte M, Greene DA, Killen PD. Altered aldose reductase gene expression in cultured human retinal pigment epithelial cells. J Clin Invest. 1993;92:617-623.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
32. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA. 1984;81:1991-1995.
33. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell. 1980;20:95-105.
34. Kador PF, Carper D, Kinoshita JH. Rapid purification of human placental aldose reductase. Anal Biochem. 1981;114:53-58.
35. Das B, Srivastava SK. Activation of aldose reductase from human tissues. Diabetes 1985;34:1145-1151.
36. Ashcroft SJH, Stubbs M. The glucose sensor in HIT cells is the glucose transporter. FEBS Lett. 1987;219:311-315.
37. Ruegg CE, Mandel LJ. Bulk isolation of renal PCT and PST, I: Glucose-dependent metabolic differences. Am J Physiol. 1990; 259:F164-F175.
38. Mantych GJ, Hageman GS, Devaskar SU. Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology. 1993;133:600-607.
39. Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 1984;33:97-100.
40. Henry DN, Brosius FC, Heilig C, Busik J. Glucose transporters control the expression of aldose reductase, PKCa, and GLUT1 genes in mesangial cells. Am J Physiol. 1999;277:F97-F104.
41. Heilig CW, Brosius FC III, Henry DN. Glucose transporters of the glomerulus and the implications for diabetic nephropathy. Kidney Int. 1997;52:S91-S99.
42. Christian, M, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest. 1998;102:619-624.
43. Ayo S, Radnik R, Garoni J, Glass W, Kreisberg J. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990;136:1339-1348
44. Henry DN, Busik JV, Olson LK, Greenidge CA, Heilig CW, Frank RN. Accelerated glucose exchange increases glucose entry into cells of the blood-retinal barrier (BRB) in vitro [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1999;40(4):S484. Abstract nr 2550.